Digestive Diseases and Sciences

, Volume 51, Issue 7, pp 1175–1178 | Cite as

Patient Retention in a Clinical Trial: A Lesson from the Rofecoxib (VIOXX) Study



A high retention rate of patients and control subjects is an important criterion for the credibility and accuracy of prospective, randomized, controlled clinical trials. Retention and adherence depend on a combination of patient-, physician- and coordinator-related factors, and these need to be carefully evaluated to ensure success. The aim of the study was to evaluate predictive factors for patient retention in a clinical trial. Questionnaires containing items on demographic and clinical data and specific questions related to patient motivation were distributed to 31 patients participating in a clinical study comparing rofecoxib (Vioxx) and placebo for the prevention of colonic polyp recurrence. Adherence of the group with the rofecoxib study and the questionnaire was 100%. The sample included 24 men (77%) and 7 women of mean age 66 ± 9 years; 90% were married, 42% were employed. A family history of colorectal cancer (CRC) was reported by 29%. The main reasons for adherence reported by the patients (on an analog scale of 0–10) were 24-hour availability of a nurse (9.2 ± 1.9), the chance to prevent CRC (9.1 ± 1.9), and participation in a multicenter study (9.1 ± 2.2). The least important factor was support of the family physician (5.8 ± 4.1). In conclusion, retention in a clinical trial mainly depends on the subject of the trial and the scientific/professional setting where it takes place, and less on the support of the family physician.


patient retention clinical trial medical research 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Buist DS, LaCroix AZ, Black DM, et al.: Inclusion of older women in randomized clinical trials: factors associated with taking study medication in the fracture intervention trial. J Am Geriatr Soc 48:1126–1131, 2000PubMedGoogle Scholar
  2. 2.
    Jonasson G, Carlsen KH, Mowinckel P: Asthma drug adherence in a long term clinical trial. Arch Dis Child 83:330–333, 2000PubMedCrossRefGoogle Scholar
  3. 3.
    Duan N, Fox SA, Derose KP, et al.: Maintaining mammography adherence through telephone counseling in a church-based trial. Am J Public Health 90:1468–1471, 2000PubMedCrossRefGoogle Scholar
  4. 4.
    Janson SL, Alioto ME, Boushey HA: Asthma Clinical Trials Network. Attrition and retention of ethnically diverse subjects in a multicenter randomized controlled research trial. Control Clin Trials 22(6 Suppl):236S–243S, 2001PubMedCrossRefGoogle Scholar
  5. 5.
    Cox KL, Burke V, Gorely TJ, et al.: Controlled comparison of retention and adherence in home- vs center-initiated exercise interventions in women ages 40-65 years: The S.W.E.A.T. Study (Sedentary Women Exercise Adherence Trial). Prev Med 36:17–29, 2003PubMedCrossRefGoogle Scholar
  6. 6.
    Froelicher ES, Miller NH, Buzaitis A, et al.: The Enhancing Recovery in Coronary Heart Disease Trial (ENRICHD): strategies and techniques for enhancing retention of patients with acute myocardial infarction and depression or social isolation. J Cardiopulm Rehabil 23:269–280, 2003PubMedCrossRefGoogle Scholar
  7. 7.
    Parra-Medina D, D'Antonio A, Smith SM, et al.: Successful recruitment and retention strategies for a randomized weight management trial for people with diabetes living in rural, medically underserved counties of South Carolina: the POWER study. J Am Diet Assoc 104:70–75, 2004PubMedCrossRefGoogle Scholar
  8. 8.
    Mullins SM, Suarez M, Ondersma SJ, et al.: The impact of motivational interviewing on substance abuse treatment retention: a randomized control trial of women involved with child welfare. J Subst Abuse Treat 27:51–58, 2004PubMedCrossRefGoogle Scholar
  9. 9.
    Landers PS, Landers TL: Survival analysis of dropout patterns in dieting clinical trials. J Am Diet Assoc 104:1586–1588, 2004PubMedCrossRefGoogle Scholar
  10. 10.
    Raymond EG, Chen PL, Pierre-Louis B, et al.: Participant characteristics associated with withdrawal from a large randomized trial of spermicide effectiveness. BMC Med Res Methodol 4:23, 2004PubMedCrossRefGoogle Scholar
  11. 11.
    Mazzuca SA, Brandt KD, Katz BP, et al.: Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drug. Arthritis Rheum 51:933–940, 2004PubMedCrossRefGoogle Scholar
  12. 12.
    Niv Y, Lev-El M, Abuksis G, et al.: Protective effect of fecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers. Gut 50:33–37, 2002PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media, Inc. 2006

Authors and Affiliations

  1. 1.Department of GastroenterologyRabin Medical CenterPetach TiqvaIsrael
  2. 2.Sackler Faculty of MedicineTel Aviv UniversityTel AvivIsrael

Personalised recommendations